Get started
Author

Tilman D. Rachner

Observed names: Rachner, Tilman, Rachner, Tilman D., Rachner, Tilman Daniel, T D Rachner, T Rachner, T. D. Rachner, T. Rachner, T.D. Rachner, T.D. Rachner⁎, TD Rachner, Tilman D. Rachner, Tilman D Rachner, Tilman Rachner
Observed institutions: Philipps University of Marburg, German Cancer Research Center, Helmholtz-Zentrum Dresden-Rossendorf, National Center for Tumor Diseases, Essen University Hospital, University Hospital Carl Gustav Carus, Nationales Centrum für Tumorerkrankungen Dresden, Deutsches Konsortium für Translationale Krebsforschung, German Cancer Research Center (DKFZ) Dresden, German Cancer Consortium (DKTK) Dresden, Technische Universität Dresden
ORCID: 0000-0002-1592-4666
Observed ORCID: 0000-0002-1592-4666
OpenAlex ID: A5000820032
Osteoporosis: now and the future
2011 · Tilman D Rachner, Sundeep Khosla, et al. · The Lancet · 2,755
Regenerative potential of glycosaminoglycans for skin and bone
2011 · Juliane Salbach, Tilman D. Rachner, et al. · Journal of Molecular Medicine · 208
Cholesterol and beyond - The role of the mevalonate pathway in cancer biology
2020 · Andy Göbel, Martina Rauner, et al. · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 175
Bone health during endocrine therapy for cancer
2018 · Tilman D Rachner, Robert Coleman, et al. · The Lancet Diabetes & Endocrinology · 151
Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells
2019 · Andy Göbel, Dorit Breining, et al. · Cell Death and Disease · 124
PDF
Endocrine aspects of bone metastases
2014 · Lorenz C Hofbauer, Tilman D Rachner, et al. · The Lancet Diabetes & Endocrinology · 120
The effect of the degree of sulfation of glycosaminoglycans on osteoclast function and signaling pathways
2012 · Juliane Salbach, Stefanie Kliemt, et al. · Biomaterials · 80
High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients
2014 · Tilman D Rachner, Stefanie Thiele, et al. · BMC Cancer · 77
PDF
Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells
2009 · Tilman D. Rachner, Shiv K. Singh, et al. · Cancer Letters · 63
p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells
2016 · A J Browne, A Göbel, et al. · Cell Death and Disease · 60
PDF
Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells
2016 · Andy Göbel, Stefanie Thiele, et al. · Cancer Letters · 55
Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates
2011 · Sylvia Thiele, Martina Rauner, et al. · Journal of Cellular Biochemistry · 55
Novel therapies in osteoporosis: PTH-related peptide analogs and inhibitors of sclerostin
2018 · Tilman D Rachner, Lorenz C Hofbauer, et al. · Journal of Molecular Endocrinology · 50
PDF
Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer
2020 · Andy Göbel, Valentina M. Zinna, et al. · BMC Cancer · 49
Skeletal and extraskeletal actions of denosumab
2012 · Kathrin Sinningen, Elena Tsourdi, et al. · Endocrine · 49
Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification
2011 · B. A. Di Bartolo, M. Schoppet, et al. · Cardiovascular Research · 48
The Role of Inflammation in Breast and Prostate Cancer Metastasis to Bone
2021 · Andy Göbel, Stefania Dell’Endice, et al. · International Journal of Molecular Sciences · 47
PDF
WNT5A Has Anti-Prostate Cancer Effects In Vitro and Reduces Tumor Growth in the Skeleton In Vivo
2014 · Stefanie Thiele, Andy Göbel, et al. · Journal of Bone and Mineral Research · 47
PDF
Prognostic Value of RANKL/OPG Serum Levels and Disseminated Tumor Cells in Nonmetastatic Breast Cancer
2018 · Tilman D. Rachner, Sabine Kasimir-Bauer, et al. · Clinical Cancer Research · 46
Evolving functions of Dickkopf-1 in cancer and immunity
2020 · Nikolai Jaschke, Lorenz C. Hofbauer, et al. · Cancer Letters · 44
Osteonecrosis of the Jaw After Osteoporosis Therapy With Denosumab Following Long-term Bisphosphonate Therapy
2013 · Tilman D. Rachner, Uwe Platzbecker, et al. · Mayo Clinic Proceedings · 41
PDF
Denosumab for bone diseases: translating bone biology into targeted therapy
2011 · Elena Tsourdi, Tilman D Rachner, et al. · European Journal of Endocrinology · 41
Dickkopf-1 as a mediator and novel target in malignant bone disease
2014 · Tilman D. Rachner, Andy Göbel, et al. · Cancer Letters · 39
Role of WNT5A receptors FZD5 and RYK in prostate cancer cells
2018 · Stefanie Thiele, Ariane Zimmer, et al. · Oncotarget · 38
PDF
Severe Abdominal Aortic Calcification in Older Men Is Negatively Associated With DKK1 Serum Levels: The STRAMBO Study
2013 · P. Szulc, M. Schoppet, et al. · The Journal of Clinical Endocrinology & Metabolism · 38
Works count: 150
Citation count: 5,435
H-index: 31
I10-index: 62
Year
Topic
Type